55 /100
HIGH RISK
Score updated May 30, 2026

KPTI — Karyopharm Therapeutics Inc. Dilution Risk Tracker

Track KPTI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KPTI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
50
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
30%
🔁 Convertible Conversion 60%
• Major convertible overhang: 66% potential dilution
• Convertible risk score very high (85/100)
🔔 Track KPTI — Get forecast alerts →

💹 Market Data

Market Cap$206.23M
Shares Outstanding22.66M
Float15.22M
Cash$90.85M
Debt$296.73M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 6.19M shares
#1 T. Rowe Price Investment Management, Inc. 1.49M shares
#2 Opaleye Management Inc. 930.0K shares
#3 Affinity Asset Advisors, Llc 889.6K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest5.28M
Days to Cover11.5
% of Float34.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
8-K 8K EVENT Mar 24, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track KPTI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KPTI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: BATL BRN CDIO CDT CNTMD
🔬 More Research for KPTI
📊 KPTI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 KPTI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.